tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RPTX Stock Latest News

Repare Therapeutics price target lowered to $3 from $4 at Stifel
The FlyRepare Therapeutics price target lowered to $3 from $4 at Stifel
12d ago
RPTX
Repare Therapeutics Shifts Focus to Phase 1 Programs
PremiumCompany Announcements
Repare Therapeutics Shifts Focus to Phase 1 Programs
12d ago
8K
RPTX
Repare Therapeutics realigning resources to extend runway to mid-2027
PremiumThe Fly
Repare Therapeutics realigning resources to extend runway to mid-2027
12d ago
RPTX
Repare Therapeutics to seek partnering opportunities across portfolio
PremiumThe Fly
Repare Therapeutics to seek partnering opportunities across portfolio
12d ago
RPTX
Repare Therapeutics announces portfolio reprioritization, partnering initiatives
PremiumThe Fly
Repare Therapeutics announces portfolio reprioritization, partnering initiatives
12d ago
RPTX
3 Best Stocks to Buy Now, 12/16/2024, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 12/16/2024, According to Top Analysts
1M ago
COP
EVGO
Repare Therapeutics downgraded to Market Perform from Outperform at LifeSci Capital
Premium
The Fly
Repare Therapeutics downgraded to Market Perform from Outperform at LifeSci Capital
1M ago
RPTX
Repare Therapeutics price target lowered to $4 from $9 at Stifel
Premium
The Fly
Repare Therapeutics price target lowered to $4 from $9 at Stifel
1M ago
RPTX
Closing Bell Movers: RH soars 20% on earnings, guidance raise
PremiumThe Fly
Closing Bell Movers: RH soars 20% on earnings, guidance raise
1M ago
NX
RH
Repare Therapeutics Shows Promise in Cancer Drug Trials
PremiumCompany Announcements
Repare Therapeutics Shows Promise in Cancer Drug Trials
1M ago
8K
RPTX
Repare Therapeutics reports ‘positive’ results from MYTHIC Phase 1 trial
PremiumThe Fly
Repare Therapeutics reports ‘positive’ results from MYTHIC Phase 1 trial
1M ago
RPTX
Repare Therapeutics announces CRADA to advance camonsertib development
PremiumThe Fly
Repare Therapeutics announces CRADA to advance camonsertib development
2M ago
RPTX
Repare Therapeutics Reports Q3 2024 Progress and Outlook
PremiumCompany AnnouncementsRepare Therapeutics Reports Q3 2024 Progress and Outlook
3M ago
RPTX
Repare Therapeutics reports Q3 EPS (81c), consensus (83c)
Premium
The Fly
Repare Therapeutics reports Q3 EPS (81c), consensus (83c)
3M ago
RPTX
Repare Therapeutics presents data from Phase 1 MYTHIC clinical trial
Premium
The Fly
Repare Therapeutics presents data from Phase 1 MYTHIC clinical trial
3M ago
RPTX
Repare Therapeutics doses first patient in POLAR trial
PremiumThe Fly
Repare Therapeutics doses first patient in POLAR trial
3M ago
RPTX
Repare Therapeutics reports ‘encouraging’ Phase 1 camonsertib combo data
PremiumThe Fly
Repare Therapeutics reports ‘encouraging’ Phase 1 camonsertib combo data
4M ago
RPTX
Repare: Endometrial cancers with CCNE1 amplifications carry poor prognosis
PremiumThe Fly
Repare: Endometrial cancers with CCNE1 amplifications carry poor prognosis
4M ago
RPTX
Repare Therapeutics Announces Strategic R&D Focus and Workforce Reduction
PremiumCompany Announcements
Repare Therapeutics Announces Strategic R&D Focus and Workforce Reduction
5M ago
8K
RPTX
Repare announces strategic reprioritization, to lay off 25% of workforce
PremiumThe FlyRepare announces strategic reprioritization, to lay off 25% of workforce
5M ago
RPTX
Repare to provide updated camonsertib data in Q4, says LifeSci Capital
Premium
The Fly
Repare to provide updated camonsertib data in Q4, says LifeSci Capital
5M ago
RPTX
Repare Therapeutics Advances Oncology Trials and Preps for 2025
Premium
Company Announcements
Repare Therapeutics Advances Oncology Trials and Preps for 2025
6M ago
RPTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >